Next Article in Journal
Are Patient-Reported Outcomes of Physical Function a Valid Substitute for Objective Measurements?
Previous Article in Journal
Radiation Therapy and Immunotherapy—A Potential Combination in Cancer Treatment
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 25
Issue 5
10.3747/co.25.4092
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia

by
C. Owen
1,*,
A. S. Gerrie
2,
V. Banerji
3,
S. Assouline
4,
C. Chen
5,
K. S. Robinson
6,
E. Lye
7 and
G. Fraser
8
1
Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary, AB T2N 2T9, Canada
2
Division of Medical Oncology, University of British Columbia and BC Cancer, Vancouver, BC V6T 1Z4, Canada
3
Department of Hematology and Medical Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada
4
Department of Medical Oncology, McGill University and Jewish General Hospital, Montreal, QC H3T 1E2, Canada
5
Department of Medical Oncology, University of Toronto, and Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada
6
Division of Hematology, Dalhousie University, and qeii Health Sciences Centre, Halifax, NS B3H 2Y9, Canada
7
Lymphoma Canada, Mississauga, ON L5N 2W5, Canada
8
Department of Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, ON L8V 5C2, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2018, 25(5), 461-474; https://doi.org/10.3747/co.25.4092
Submission received: 5 July 2018 / Revised: 6 August 2018 / Accepted: 10 September 2018 / Published: 1 October 2018

Abstract

Chronic lymphocytic leukemia (cll) is the most common adult leukemia in North America. In Canada, no unified national guideline exists for the front-line treatment of cll; provincial guidelines vary and are largely based on funding. A group of clinical experts from across Canada developed a national evidence-based treatment guideline to provide health care professionals with clear guidance on the first-line management of cll. Consensus recommendations based on available evidence are presented for the first-line treatment of cll.
Keywords: chronic lymphocytic leukemia; cll; treatment; prognosis; fitness chronic lymphocytic leukemia; cll; treatment; prognosis; fitness

Share and Cite

MDPI and ACS Style

Owen, C.; Gerrie, A.S.; Banerji, V.; Assouline, S.; Chen, C.; Robinson, K.S.; Lye, E.; Fraser, G. Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia. Curr. Oncol. 2018, 25, 461-474. https://doi.org/10.3747/co.25.4092

AMA Style

Owen C, Gerrie AS, Banerji V, Assouline S, Chen C, Robinson KS, Lye E, Fraser G. Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia. Current Oncology. 2018; 25(5):461-474. https://doi.org/10.3747/co.25.4092

Chicago/Turabian Style

Owen, C., A. S. Gerrie, V. Banerji, S. Assouline, C. Chen, K. S. Robinson, E. Lye, and G. Fraser. 2018. "Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia" Current Oncology 25, no. 5: 461-474. https://doi.org/10.3747/co.25.4092

Article Metrics

Back to TopTop